Company
tavobio.com
Tavo Biotherapeutics is a biotech company developing novel treatments for glaucoma and retinal diseases.
Also known as Tavo Biotherapeutics, Tavo Biotherapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Tavo Biotherapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Tavo Biotherapeutics is focused on developing novel therapeutics aimed at addressing significant unmet medical needs in ophthalmology, with a particular emphasis on preserving vision and improving long-term outcomes for patients with glaucoma and retinal disease.
Funding snapshot
- Total raised
- $17MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $17M2026-06-02
Funding rounds
- Series A
- $17M2026-06-02, Company stated
Products
- Other
- TAV-001
- Other
- TAV-002
Loading relationship preview